The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Abstract
There is a pressing need for additional treatment options for refractory mood disorders. This controlled comparative study evaluated the efficacy of lamotrigine (LTG) and gabapentin (GBP) monotherapy versus placebo (PLC). Thirty-one patients with refractory bipolar and unipolar mood disorders participated in a double-blind, randomized, crossover series of three 6-week monotherapy evaluations including LTG, GBP, and PLC. There was a standardized blinded titration to assess clinical efficacy or to determine the maximum tolerated daily dose (LTG 500 mg or GBP 4,800 mg). The primary outcome measure was the Clinical Global Impressions Scale (CGI) for Bipolar Illness as supplemented by other standard rating instruments. The mean doses at week 6 were 274 +/- 128 mg for LTG and 3,987 +/- 856 mg for GBP. Response rates (CGI ratings of much or very much improved) were the following: LTG, 52% (16/31); GBP, 26% (8/31); and PLC, 23% (7/31) (Cochran's Q = 6.952, df = 2, N = 31, p = 0.031). Post hoc Q differences (df = 1, N = 31) were the following: LTG versus GBP (Qdiff = 5.33, p = 0.011); LTG versus PLC (Qdiff = 4.76, p = 0.022); and GBP versus PLC (Qdiff = 0.08, p = 0.70). With respect to anticonvulsant dose and gender, there was no difference between the responders and the nonresponders. The agents were generally well tolerated. This controlled investigation preliminarily suggests the efficacy of LTG in treatment-refractory affectively ill patients. Further definition of responsive subtypes and the role of these medications in the treatment of mood disorders requires additional study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are insufficient data to make a recommendation regarding the use of aspirin (adjunctive) (level 3 negative),296 celecoxib (adjunctive) (level 3 negative),297 gabapentin (monotherapy) (level 3 negative),298 leviteracitam (adjunctive) (level 3 negative),299 lisdexamfetamine (adjunctive) (level 3 negative),300 memantine (adjunctive) (level 3),301 pioglitazone (adjunctive) (level 3),302, 303 ril”
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Spearing, M. K., Post, R. M., Leverich, G. S., Brandt, D., & Nolen, W. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00123-6 · Cited by 978
Self-citationA summary of mechanistic hypotheses of gabapentin pharmacology
Taylor, C. P., Gee, N. S., Su, T.-Z., Kocsis, J. D., Welty, D. F., Brown, J. P., Dooley, D. J., Boden, P., & Singh, L. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(97)00084-3 · Cited by 774
Leach, M. J., Marden, C. M., & Miller, A. A. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03573.x · Cited by 549
Clinical Factors in Lithium Carbonate Prophylaxis Failure
Dunner, D. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760080077013 · Cited by 514
Depression During Mania: Treatment Response to Lithium or Divalproex
Swann, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130041008 · Cited by 374
Outcome of Bipolar Disorder on Long-Term Treatment with Lithium
O'Connell, R. A., Mayo, J. A., Flatow, L., Cuthbertson, B., & O'Brien, B. E. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.159.1.123 · Cited by 333
Research works printed but not linked: 11
- Bowden, 1994, JAMA, 271, 918, 10.1001/jama.271.12.918 · doi:10.1001/jama.271.12.918 · Paper page
- Himmelhoch, 1986, Psychopharmacol Bull, 22, 613
- Otsuki, 1995, Jpn J Neuropsychopharmacol, 17, 35
- Calabrese, 1996, Am J Psychiatry, 153, 1236
- Labbate, 1997, Am J Psychiatry, 154, 1317
- Kusumakar, 1997, Am J Psychiatry, 154, 1171
- Stanton, 1997, Am J Psychiatry, 154, 287
- Leverich, 1996, Curr Rev Mood Anxiety Disord, 1, 48
- Overall, 1962, Psychol Rep, 10, 799, 10.2466/PR0.10.3.799-812 · doi:10.2466/pr0.10.3.799-812 · Paper page
- Kraemer, 1991, Psychopharmacol Bull, 3, 217
- Cora-Locatelli, 1998, J Clin Psychiatry, 59, 400
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationGoodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
What Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Bowden, C. L. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.4.392 · Cited by 658
Metadata
- Authors
- Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M.
- Affiliations
- National Institutes of Health (US)
- Stanford Medicine (US)
- Corresponding author
- Frye, Mark A.
- Kimbrell, Timothy A.
- Dunn, Robert T.
- Speer, Andrew M.
- Osuch, Elizabeth A.
- Luckenbaugh, David A.
- Leverich, Gabriele S.
- Post, Robert M.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2000-12
- Volume
- 20
- Issue
- 6
- Pages
- 607-614
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2037231243
- Cited by
- 446
- References
- 57
- Citations by year
- 2025: 3 · 2024: 6 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 8 · 2016: 15 · 2015: 7 · 2014: 5 · 2013: 6 · 2012: 20
- FWCI
- 29.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- lamotrigine, gabapentin, bipolar disorder, major depressive disorder, anticonvulsant monotherapy, Clinical Global Impression Scale, drug efficacy, tolerability, dose titration
- MeSH terms
- Gabapentin, Lamotrigine, Acetates, Adult, Amines, Cyclohexanecarboxylic Acids, Double-Blind Method, Female, gamma-Aminobutyric Acid, Humans, Male, Middle Aged, Placebos, Psychiatric Status Rating Scales, Triazines, Treatment Outcome, Cross-Over Studies, Antimanic Agents, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders. https://app.cochat.ai/papers/10.1097/00004714-200012000-00004
- The paper
- Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000). A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-200012000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.